US90384S3031 - Common Stock
2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 8.631B 40.30% | 10.209B 18.28% | 11.207B 9.78% | 12.015B 7.21% | |||||||
EBITDA YoY % growth | 1.566B 141.29% | 1.88B 20.11% | 1.922B 2.21% | 1.993B 3.70% | |||||||
EBIT YoY % growth | 1.297B 269.52% | 1.639B 26.37% | 1.678B 2.38% | 1.732B 3.22% | |||||||
Operating Margin | 15.03% | 16.05% | 14.97% | 14.42% | |||||||
EPS YoY % growth | 17.98 280.13% | 24.02 33.59% | 26.05 8.45% | 27.24 4.58% |
All data in USD
Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 6.48 -5.80% | |||||||||||
Revenue Q2Q % growth | 2.797B 6.18% | |||||||||||
EBITDA Q2Q % growth | 488.51M | |||||||||||
EBIT Q2Q % growth | 410.06M -7.25% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2024 Q2Q % growth | 8.08 20.96% | 7.68 | 0.40 | 5.21% |
Q3 2024 Q2Q % growth | 5.07 -5.06% | 5.05 | 0.02 | 0.40% |
Q2 2024 Q2Q % growth | 6.02 5.61% | 5.97 | 0.05 | 0.84% |
Q1 2024 Q2Q % growth | 6.88 9.21% | 7.01 | -0.13 | -1.81% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2024 Q2Q % growth | 3.554B 10.15% | 3.6B | -45.702M | -1.27% |
Q3 2024 Q2Q % growth | 2.489B 6.42% | 2.518B | -29.1M | -1.16% |
Q2 2024 Q2Q % growth | 2.53B 10.13% | 2.559B | -29.2M | -1.14% |
Q1 2024 Q2Q % growth | 2.634B 12.29% | 2.672B | -37.7M | -1.41% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | -10.96% | -10.9% | -0.99% | -1.47% |
Revenue | -0.96% | -2.34% | 0.79% | 0.92% |